Demand Dividend
A self-liquidating preferred-equity structure that repays the investor from free cash flow after a health-of-business test, capped by a negotiated return multiple.
Also known as: variable dividend redeemable preferred stock, variable dividend preferred, self-liquidating preferred equity.
A demand dividend is built for the enterprise that can plausibly return capital from operations but will not produce a venture-style exit. The investor does not wait for a sale, and the enterprise does not carry fixed debt service in weak months. Instead, payment begins only after the business clears an agreed health test, then continues as a share of available cash until a capped return has been paid.
Context
Family offices meet this pattern in the same missing-middle territory where revenue-based finance, recoverable grants, and patient direct investments appear. The enterprise is too established for a grant-only relationship and too mission-bound, local, or founder-controlled for conventional venture equity. It may sell essential services, community infrastructure, agricultural products, health access, or education tools. It has customers. It has margins. It does not have an obvious acquirer, public-market path, or appetite for a fixed amortization schedule.
The demand dividend grew out of impact-investing work at Santa Clara University’s Miller Center for Social Entrepreneurship, through its Global Social Benefit Institute (GSBI) accelerator. John Kohler, Thomas Kreutzer, and Henry Brzezinski named it in 2013 as an answer to a specific financing gap: enterprises that need growth capital and can share future cash flow, but whose mission and ownership structure make exit-dependent equity a poor fit.
The instrument is usually documented as redeemable preferred equity or an equivalent contractual claim. The investor receives a preferred position, an early payment holiday, a health-of-business test, a variable dividend formula, and a return cap. Once cumulative payments reach the cap, the investor is redeemed or the obligation ends.
Problem
The office wants capital to come back so it can be redeployed, but the enterprise cannot safely borrow on fixed terms and will not deliver an equity exit. Ordinary debt may pull cash out before the new product line, distribution channel, or working-capital cycle has matured. Ordinary equity may ask the founder to optimize for a sale the mission does not need.
A straight grant avoids the repayment problem but gives up the recycling discipline. A revenue-share note can work when top-line revenue is the cleanest repayment base, but it can still take cash when operating margins are thin. A demand dividend asks a narrower question: can the enterprise pay from available cash after reserves and operating needs, on a schedule that bends with business health?
Get the structure wrong and it becomes disguised debt. A high cap, no holiday, and a vague cash-flow test can extract more than a fixed loan would have taken, while still letting the office describe the deal as patient capital.
Forces
- Enterprise breathing room versus investor payback. The enterprise needs time to use the capital before payments begin, while the office needs a credible path to return.
- Free-cash-flow test versus reporting burden. A health test protects the business, but it requires financial reporting the enterprise may not already produce.
- Return cap versus concession. A low cap expresses impact-first patience; a high cap can turn the instrument into expensive quasi-debt.
- Founder control versus investor protection. The structure preserves ownership and mission control, but the investor needs information rights, audit rights, and default remedies for bad reporting.
- Capital recycling versus impact claim. Returning capital proves the instrument worked financially. It doesn’t prove the enterprise produced the intended outcome.
Solution
Use a demand dividend when the office can write five terms cleanly: payment holiday, health-of-business test, available-cash formula, return cap, and redemption end point.
Start with the payment holiday. The capital should have time to create the capacity it funds, usually twelve to twenty-four months for an early growth-stage enterprise. No dividend is due during that period unless the business outperforms the plan and voluntarily accelerates payment.
Then define the health test. A strong test names the cash reserve, coverage ratio, margin floor, or working-capital threshold that must be met before any dividend is paid. “When funds are available” is too loose. “Quarterly dividends begin only when unrestricted cash exceeds ninety days of operating expense and debt-service coverage remains above 1.25x” is underwritable.
Set the dividend as a share of free cash flow, not gross revenue. The agreement should define the base: cash receipts less direct cost of goods, payroll, taxes, approved capex reserve, debt service, and an operating reserve. The office may take 20% to 40% of that available cash, but the number matters less than the margin test. A formula that leaves the business unable to grow defeats the point.
Finally, cap the total return. Demand-dividend papers commonly discuss caps in the 1.5x to 3.0x range, depending on risk, tenor, and concession. For an impact-first family office, the cap is where the mandate becomes visible. A 1.5x cap over eight years says something different from a 3.0x cap over five years. Both may be defensible. They are not the same claim.
A demand dividend should not be used to avoid the discipline of debt documents or PRI analysis. If the enterprise owes fixed payments regardless of business health, the structure is no longer doing the work this pattern names.
How It Plays Out
Consider a $950M single-family office with a $35M direct-impact sleeve focused on rural health access. A clinic-network software company serves independent clinics in three states. It has $3.8M of recurring revenue, positive unit economics, and a 13% operating margin, but it needs $750,000 to build billing integrations and hire implementation staff. The founder wants to stay independent. A bank will lend at 10.25% over five years with a personal guarantee. Venture equity wants a growth plan built around a later strategic sale.
The office sees a real capital gap. The company can pay if the expansion works, but fixed debt would bite before the new clinics are onboarded, and equity would push the company toward an exit path the founder doesn’t want. The office offers a demand dividend:
| Term | Design |
|---|---|
| Capital advanced | $750,000 redeemable preferred investment. |
| Payment holiday | 18 months. |
| Health test | Dividends only after unrestricted cash exceeds 90 days of operating expense and gross margin stays above 45% for two quarters. |
| Dividend base | 30% of quarterly free cash flow after payroll, taxes, approved capex, debt service, and operating reserve. |
| Return cap | 1.8x, or $1.35M total return of capital and preferred dividend. |
| End point | Redemption at cap or year eight, with any unpaid balance reviewed by the committee. |
For the first eighteen months, the company pays nothing. It uses the capital to finish integrations and bring twenty-eight clinics onto the platform. In year three, free cash flow after reserves is $310,000. The company pays $93,000 that year. In year four, free cash flow rises to $620,000 and the dividend is $186,000. If the growth plan holds, the office reaches the $1.35M cap in year six or seven and recycles the capital into the next deal.
The structure is not magic. If the company never clears the health test, the office waits, writes down the position, or renegotiates. If the company grows faster than expected, the founder still keeps ownership after the cap is paid. The office gave up uncapped upside in exchange for mission-preserving control, flexible repayment, and a defined recycling path.
A weak version looks similar in the term sheet and different in the cash file. The office advances the same $750,000, requires payment from month one, takes 50% of free cash flow, sets a 3.0x cap, and lets the operating reserve be approved by the investor alone. The company starts deferring implementation work to make the dividend. The family reports a patient-capital deal. In practice, it built a heavier burden than the bank loan.
Consequences
Benefits. The pattern gives the office a return path without forcing an exit. It protects founder control, fits enterprises with uneven but real cash generation, and lets capital recycle after the cap is met. It also makes the concession legible: payment waits for business health, the return is capped, and the investor accepts timing risk.
The structure composes well with adjacent instruments. A foundation may provide a grant for technical assistance, a DAF may use a recoverable grant for a pilot, and the family-office balance sheet may hold the demand dividend once the enterprise has enough operating evidence. A co-investment club can split the preferred position if the monitoring burden is too large for one office.
Liabilities. The instrument is document-heavy. The office needs counsel, tax review, accounting treatment, financial reporting, audit rights, and a committee willing to monitor free-cash-flow calculations. A small ticket can become uneconomic if the office builds the same legal file it would use for a much larger direct investment.
The cap also creates a tradeoff. If the enterprise later becomes highly valuable, the office’s upside is limited by design. If the cap is set too high, the office has not been patient; it has priced equity-like risk into a structure that may be harder for the business to carry than debt.
The second-order effect is claim discipline. A demand dividend can show that the office used flexible capital on terms a bank or venture investor would not provide. It can’t, by itself, show that clinics served more patients, farmers earned more income, or households became more resilient. The impact claim still needs a theory of change, outcome metrics, and evidence that the capital changed what happened.
Related Articles
Sources
- John Kohler, Thomas Kreutzer, and Henry Brzezinski, Demand Dividend: Creating Reliable Returns in Impact Investing, Santa Clara University Miller Center for Social Entrepreneurship / GSBI, 2013 — the originating paper naming the instrument and its payment holiday, business-health test, capped return, and self-liquidating design.
- Miller Center for Social Entrepreneurship, GSBI Investor Readiness materials, current access 2026 — practitioner curriculum placing demand dividends inside the structured-exit toolkit for impact enterprises that need growth capital without venture-style exit pressure.
- Inter-American Development Bank / Multilateral Investment Fund, Innovations in Financing Structures for Impact Enterprises: A Spotlight on Latin America, 2018 — development-finance treatment of variable-payment and quasi-equity structures for enterprises whose cash-flow profile does not fit ordinary debt or equity.
- Transform Finance, Transformative Financing Structures, current access 2026 — patient-capital framing for self-liquidating and founder-protective structures that limit extractive capital dynamics while still returning capital.
This entry describes a structural and investment-governance pattern and is not legal, tax, or investment advice. Consult qualified counsel and tax advisors licensed in your jurisdiction before adopting any demand-dividend, preferred-equity, securities, tax, accounting, or fiduciary structure described here.